Severe reversible acute renal failure in idiopathic nephrotic syndrome

Journal of Nephrology

Volumn 23, Issue 6, 2010, Pages 717-724

  Stellato, Tiziana ^a   Cappelleri, Anna ^a   Farina, Marco ^b   Pisano, Lucia ^c   Scanziani, Renzo ^c   Meroni, Mietta ^c   Banfi, Giovanni ^d   Imbasciati, Enrico ^a   Stella, Andrea ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Lodi Hospital   (Italy)

^c DESIO HOSPITAL   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Acute renal failure; Minimal changes nephrotic syndrome; Nephrotic syndrome; Prednisone; Proteinuria; Tubular necrosis

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; EPITHELIUM CELL; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE BASEMENT MEMBRANE; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PROTEINURIA; RELAPSE; REMISSION; SIDE EFFECT; STEROID THERAPY; THROMBOCYTOPENIA; TREATMENT DURATION;

ACUTE KIDNEY INJURY; ADULT; AGED; BIOPSY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; RENAL DIALYSIS;

EID: 78549258508     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Smith JD, Hayslett JP. Reversible renal failure in the nephrotic syndrome. Am J Kidney Dis. 1992;19:201-213.
2. Tinawi M, Salinas-Madrigal L, Domoto D. Minimal changes disease presenting with acute tubular necrosis. Am J Kidney Dis. 1995;25:648-650.
3. Cameron MA, Peri U, Rogers TE, Moe OW. Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis. Nephrol Dial Transplant. 2004;19:2642-2646.
4. Waldman M, Crew RJ, Valeri A, et al. Adult minimal change disease: clinical characteristics, treatment and outcomes. Clin J Am Soc Nephrol. 2007;2:445-453.
5. Haas M, Spargo BH, Wit EJ, Meehan SM. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis. 2000;35:433-447.
6. Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man; analysis of 57 renal biopsies and a comparison with glicerol model. Medicine. 1979;58:362-376.
7. International study of kidney disease in children: nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int. 1983;24:377-385.
8. Hopper J Jr, Ryan P, Lee JC, Rosenau W. Lipoid nephrosis in 31 adult patients: renal biopsy study by light, electron, and fluorescence microscopy with experience in treatment. Medicine. 1970;49:321-341.
9. Nolasco F, Cameron JS, Heywood EF, Hicks J, Ogg C, Williams DG. Adult onset minimal change nephrotic syndrome; a long term follow-up. Kidney Int. 1986;29:1215-1223.
10. Lowenstein J, Schacht RG, Baldwin DS. Renal failure in minimal change nephrotic syndrome. Am J Med. 1981;70:227-233. (Pubitemid 11146003)
11. Raij L, Keane WF, Leonard A, Shapiro FL. Irreversible acute renal failure in idiopathic nephrotic syndrome. Am J Med. 1976;61:207-214.
12. Imbasciati E, Ponticelli C, Case N, et al. Acute renal failure in idiopathic nephrotic syndrome. Nephron. 1981;28:186-191. (Pubitemid 11014626)
13. Esparza AR, Kahn SI, Garella S, Abuelo JG. Spectrum of acute renal failure in nephrotic syndrome with minimal change (or minor) glomerular lesions. Lab Invest. 1981;45:510-521. (Pubitemid 12196490)
14. Jennette JC, Falk RJ. Adult minimal change glomerulopathy with acute renal failure. Am J Kidney Dis. 1990;16:432-437.
15. Chamberlain MJ, Pringle A, Wrong OM. Oliguric renal failure in the nephrotic syndrome. Q J Med. 1966;35:215-235.
16. Schrier RW, Fassett RG. A critique of the overfill hypothesis of sodium and water retention in nephrotic syndrome. Kidney Int. 1998;53:1111-1117. (Pubitemid 28316870)
17. Dorhout Mees EJ, Geers AB, Koomans HA. Blood volume and sodium retention in the nephrotic syndrome: a controversial pathophysiological concept. Nephron. 1984;36:201-211.
18. Usberti M, Federico S, Meccariello S, et al. Role of plasma vasopressin in the impairment of water excretion in nephrotic syndrome. Kidney Int. 1984;25:422-429. (Pubitemid 14142832)
19. Rahman SN, Abraham WT, Van Putten VJ, Hasbargen JA, Schrier RW. Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: Evidence for primary sympathetic activation. Am J Nephrol. 1993;13:266-270.
20. Peterson C, Madsen B, Perlman A, Chan AY, Myers BD. Atrial natriuretic peptide and renal response to hypervolemia in nephrotic humans. Kidney Int. 1988;34:825-831. (Pubitemid 19001701)
21. Dorhout Mees EJ, Roos CJ, Boer P, Yoe CH, Simatupang TA. Observations of edema formation in the nephrotic syndrome in adult with minimal lesions. Am J Med. 1979;67:378-384. (Pubitemid 10237019)
22. Meltzer JI, Keim HJ, Laragh JH, Sealey JE, Jan KM, Chien S. Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med. 1979; 92: 688-696.
23. Pedersen EB, Danielsen H, Madsen M, Jensen T. Increased atrial natriuretic peptide in the nephrotic syndrome. Relationship to the renal function and the renin-angiotensin-aldosterone system. Scand J Clin Lab Invest. 1988;48:141-147.
24. Brown EA, Sagnella GA, Jones BE, Squires M, Jones BE, MacGregor GA. Evidence that some mechanisms other then the renin system causes sodium retention in nephrotic syndrome. Lancet. 1982;2:1237-1240. (Pubitemid 13240858)
25. Koomans HA, Geers AB, van de Meiracker AH, Roos JC, Boer P, Dorhout Mees EJ. Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome. Am J Nephrol. 1984;4:227-234.
26. Brown EA, Markandu ND, Sagnella GA, Jones BE, McGregor GA. Lack of effect of captopril on the sodium retention in the nephrotic syndrome. Nephron. 1984;37:43-48. (Pubitemid 14152938)
27. Peterson C, Madsen B, Perlman A, Chan AY, Myers BD. Atrial natriuretic peptide and renal response to hypervolemia in nephrotic humans. Kidney Int. 1988; 34: 825-831. (Pubitemid 19001701)
28. Shang-Jyh H, Juei-Hsiung T, Yung-Hsiung L, Jenq-Horn C. Plasma atrial natriuretic peptide and natriuretic response to water immersion in patients with nephrotic syndrome. Nephron 1991;58:330-338.
29. Perico N, Remuzzi G. Edema of the nephrotic syndrome: the role of the atrial natriuretic peptide. Am J Kidney Dis. 1993; 22:355-366. (Pubitemid 23263609)
30. Zacchia M, Trepiccione F, Morelli F, Pani A, Capasso G. Nephrotic syndrome: new concepts in the pathophysiology of sodium retention. J Nephrol. 2008;21:836-842.
31. Vande Walle JG, Donckerwolcke RAMG, van Isselt JM, et al. Volume regulation in children with early relapse of minimal change nephrosis with or without hypovolemic symptoms. Lancet. 1995;346:148-152.
32. Sala C, Bedogna V, Gammaro L, Valvo E, Del Bo A, Morganti A. Central role of vasopressin in sodium/water retention in hypo- and hypervolemic nephrotic patients: a unifying hypothesis. J Nephrol. 2004;17:653-657. (Pubitemid 40484577)
33. Vande Walle JG, Mauel R, Raes A, Vandekerckhove K, Donckerwolcke R. ARF in children with minimal changes nephrotic syndrome may be related to functional changes of the glomerular basal membrane. Am J Kidney Dis. 2004;43:399-404. (Pubitemid 38298198)
34. Guash A, Myers B. Determinants of glomerular hypofiltration in nephrotic patients with minimal changes nephropathy. J Am Soc Nephrol. 1994;4:1571-1581. (Pubitemid 24977032)
35. Drummond MC, Kristal B, Myers BD, Deen WM. Structural basis for reduced filtration capacity in nephrotic syndrome. J Clin Invest. 1994;94:1187-1195. (Pubitemid 24286462)
36. Abbate M, Zoia C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol. 2006;17:2974-2984